Inventor
Bingzheng LU
Inventor
CN
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07KPeptides17%
C12NMicroorganisms or enzymes17%
PatentTitleYear
12,594,282Use of small molecule compounds in the treatment of diseases mediated by lung epithelial cell injury and/or vascular endothelial cell injury202612,319,750Hexokinase 2-specific inhibitors for use in acute central nervous system injury202511,911,396Use of compound in preparation of drug for treating cerebral small vessel disease202411,584,802Hexokinase 2-specific inhibitors for use in acute central nervous system injury2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to GUANGZHOU CELLPROTEK PHARM CO LTD (3)· patent assignee history
2023–2026Based in CN· patent location history
2026Patents assigned to GUANGZHOU CELLPROTEK PHARMACEUTICAL CO LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GUANGZHOU CELLPROTEK PHARM CO LTD | 3 | 2023–2025 |
| GUANGZHOU CELLPROTEK PHARMACEUTICAL CO LTD | 1 | 2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 4 | 2023–2026 |